Compare Consolidated Edison, Inc. (ED) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Consolidated Edison, Inc. vs Johnson & Johnson — how do they compare? Consolidated Edison, Inc. trades at $106.1 (market cap $39.20B), while Johnson & Johnson trades at $261.44 (market cap $618.09B). The key difference: Johnson & Johnson is far larger — about 15.8× Consolidated Edison, Inc.'s market cap, and Consolidated Edison, Inc. pays the higher dividend (3.31%). Which is the better fit depends on your goals — on Pluang, investors hold Consolidated Edison, Inc. for 75 Days and Johnson & Johnson for 129 Days on average.
| ED | JNJ | |
|---|---|---|
Market Cap | $39.20B | $618.09B |
Volume | 2,142,900 | 6,050,983 |
Sector | Utilities | Health |
52-Week High | $115.46 | $278.43 |
52-Week Low | $95.37 | $186.00 |
Typical Hold Time | 75 Days | 129 Days |
Enterprise Value | $66.05B | $646.37B |
Dividend Yield | 3.31% | 2.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Consolidated Edison (ED) trades at $105.99, up 1.28% on the day, with a neutral technical outlook and mixed earnings history. The stock shows stable fundamentals with a P/E of 17.43 and net income margin of 12.53%, supported by consistent revenue growth and a strong dividend track record. Recent news highlights its economic impact in New York and upcoming investor presentations.
Outlook is balanced with a consensus price target of $106.33, slightly above current levels. Risks include debt levels and regulatory pressures, but the company's utility model offers defensive appeal. Analyst sentiment is cautious with 62.96% hold ratings, reflecting steady but modest growth prospects amid economic uncertainty.
Johnson & Johnson (JNJ) trades at $256.48, down 0.76% on the day, with the stock showing mixed technical signals amid a bearish overall trend. The company maintains strong fundamentals with $94.19B in 2025 revenue, 21.48% net income margin, and consistent earnings beats in recent quarters. Recent analyst coverage shows 52.5% buy ratings with a $286.53 consensus price target, while technical indicators point to key support at $248 and resistance at $258.
JNJ presents a compelling long-term investment case with robust profitability, diversified healthcare portfolio, and dividend stability, though near-term headwinds include patent expirations and competitive pressures. The stock's current valuation at 29.75 P/E appears reasonable given strong cash flow generation and pipeline innovation, with upside potential to analyst targets if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Consolidated Edison, Inc.
Con Ed is a holding company for Consolidated Edison of New York, or CECONY, and Orange & Rockland, or O&R. These utilities provide steam, natural gas, and electricity to customers in southeastern New York—including New York City—and small parts of New Jersey. The two utilities will generate nearly all of Con Ed's earnings once it closes the sale of its clean energy business to RWE. Con Ed's clean energy business owns the second-largest portfolio of utility-scale solar projects in the U.S. Following the sale, Con Ed's only non-utility earnings will come from investments in gas and electric transmission.
Read more on ED →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
